Cargando…
Hemorrhagic pericarditis associated with rivaroxaban in an atrial fibrillation patient with pacemaker
Rivaroxaban is a new oral anticoagulant used for the prevention of stroke in patients with atrial fibrillation. Hemorrhagic pericarditis is known to occur with rivaroxaban; however, only a few case reports in the literature describe such events. Recently, we experienced hemorrhagic pericarditis that...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Korean Society for Clinical Pharmacology and Therapeutics
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7033380/ https://www.ncbi.nlm.nih.gov/pubmed/32095464 http://dx.doi.org/10.12793/tcp.2017.25.3.138 |